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ABSTRACT 
The aim of the present study was to compare the outcomes of patients with a displaced 
calcaneal fracture treated by open reduction and internal fixation (ORIF), percutaneous 
treatment, or nonoperative methods. A retrospective cohort study was conducted at a level 
I trauma center of patients with a displaced intra-articular calcaneal fracture treated from 
January 1, 2002 to December 31, 2011. The patient-reported outcome measures included 
the Foot Function Index, American Orthopaedic Foot and Ankle Society hindfoot scale, 
Short Form-36, the EQ-5D from the EuroQol Group, and a 10-point visual analog scale. 
Clinical data were collected from 169 patients, and questionnaires were obtained from 78 
patients (18 nonoperatively, 27 ORIF, and 33 percutaneously). The late intervention rate 
was significantly greater in the percutaneous group (N=18; 30%) than in the ORIF group 
(N=6; 12%) or the nonoperative group (N=8; 13%; p=.030). Significantly more disability 
was reported in the nonoperative group (median Foot Function Index score, 40 points) than 
in the ORIF group (median, 16 points; p=.010) or in the percutaneous group (median, 21 
points; p=.034). In conclusion, the operatively treated patients (ORIF and percutaneous 
treatment) reported better functional outcome scores (Foot Function Index and American 
Orthopaedic Foot and Ankle Society hindfoot scale) than did the nonoperatively treated 
patients. 
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INTRODUCTION 
Displaced intra-articular calcaneal fractures will occur mainly (60%) in patients who are 
still in their wage-earning period (i.e., 30 to 50 years old). The interval to work resumption 
has often been 5 to 10 months (1). A considerable number of patients will not be able to 
resume work within 1 year (2,3). These fractures can remain symptomatic for 1 to 2 years 
and can lead to the need for secondary arthrodesis in up to 16% of the nonoperatively 
treated patients (1,4).  
In the Netherlands, the most frequently applied treatment modalities have been 
open reduction and internal fixation (ORIF; 46%), nonoperative treatment (39%), and 
percutaneous treatment (10%) (5).  
Six meta-analyses of 4 randomized controlled trials, 1 prospective cohort study, 
and 3 retrospective studies have indicated a trend toward an overall improved outcome 
(e.g., work resumption, prevalence of complications, functional outcome, and shoe 
adjustments) in patients treated with ORIF (6–11). However, because most studies were 
powered for specific outcomes and used different outcome scores, no definitive answer to 
the best treatment can be given. To minimize surgical complications such as infection or 
nerve damage after calcaneal fracture repair, different minimally invasive, percutaneous 
techniques have been introduced (12,13). The percutaneous techniques have not been 
investigated as extensively as ORIF.  
The primary aim of the present study was to examine the effect of ORIF, 
percutaneous, and nonoperative treatment using the Foot Function Index in adult patients 
who had sustained a displaced intra-articular calcaneal fracture. In addition, the effect of 
treatment on health-related quality of life, overall patient satisfaction, interval to work 
resumption, and the prevalence of complications and late interventions was examined. 
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PATIENTS AND METHODS 
All consecutive patients with a displaced intra-articular calcaneal fracture (“International 
Classification of Diseases, 10th revision” code S92.06) (14) treated at a level I trauma 
center from January 1, 2002 to December 31, 2011 were considered eligible for the present 
retrospective case series. The patients were identified from patient registries using the 
Diagnosis Related Group for both diagnosis (code 236; calcaneal fracture) and surgery 
(code 339732; operative treatment calcaneal fracture). Fracture management consisted of 
ORIF, percutaneous treatment, or nonoperative treatment. 
The patients were treated by a general orthopedic surgeon (Monday and Thursday) 
or an orthopedic trauma surgeon (the rest of the week). Both had different local 
preferences. Because of the retrospective nature of our study, the treatment choice could 
not be determined on a case basis. A general orthopedic surgeon (B.W.) primarily 
conducted the nonoperative management (19 of 24 patients, 79%), and the orthopedic 
trauma surgeons (D.D.H., T.S.) preferred operative management (105 of 145 patients, 
72%). Until June 1, 2005, the primary operative management in this group was 
percutaneous treatment (33 of 33 patients, 100%). After June 1, 2005, the policy was 
changed to ORIF (48 of 72 patients, 67%), based on the available evidence. Surgeon 
experience with a certain technique and preference was the decisive factor between the 
choice of ORIF and percutaneous treatment. The other reasons for surgery included open 
or fracture dislocation. 
The inclusion criteria for patient selection were an intra-articular calcaneal fracture 
with more than 2 mm of displacement (i.e., Sanders type II to IV) and age 16 to 70 years. 
The exclusion criteria were primary arthrodesis or amputation, a Gustilo grade III open 
fracture, known alcohol or drug abuse, and wheelchair-bound patients with a neurologic 
disability before, or caused by, the injury. Secondary arthrodesis was considered a 
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complication of primary treatment and was included in the analysis. Functional outcome 
was determined after the patients had provided written informed consent. Patients with 
American Society of Anesthesiologists class IV, those who had died, those with an 
unknown address or who had moved abroad, patients without trauma radiographs, and 
patients with an ongoing psychiatric illness or insufficient comprehension of the Dutch or 
English language to understand the study documents were also excluded. The local 
medical research ethics committee approved the study.  
The patients received 1 of 3 different treatment modalities. Nonoperative 
management consisted of early non-weightbearing movement exercises or a plaster-of-
Paris cast. In this cohort, closed reduction by external compression (molding) was not 
performed.  
The current reference standard for the treatment of displaced intra-articular 
calcaneal fractures is ORIF using an extended lateral approach. In most cases, a sharp 100° 
to 110° angled incision was used, with the vertical limb situated almost over the lateral 
edge of the Achilles tendon. The fracture was fixed using a titanium nonlocking calcaneal 
plate (Synthes Bettlach GmbH, Bettlach, Switzerland), using titanium 3.5-mm screws (15). 
Percutaneous treatment, as described by Forgon and Zadravecz (16) and Zadravecz 
and Szekeres (17) was performed using three 3.0-mm Kirschner wires inserted through the 
tuberosity of the calcanei, talar neck, and cuboid. A distracting force was applied with an 
external fixator between the talus and calcaneus and between the talus and cuboid. 
Additional Kirschner wires were used as “joysticks” to reduce the posterior facet. 
Osteosynthesis was performed under fluoroscopic control with 6.5-mm cannulated Biomet 
(Biomet NL, Dordrecht, The Netherlands) or 7.3-mm Synthes (Synthes Bettlach GmbH) 
screws (18). 
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The patient characteristics (i.e., gender, age at trauma, and comorbidities), fracture 
characteristics (i.e., affected side, trauma mechanism, and injury classification), treatment 
characteristics (i.e., treatment type, open or closed approach, and duration of plaster 
immobilization and non-weightbearing), complications, and late interventions were 
obtained from the electronic patient files. Data were collected by 5 of us (A.S.D.B., B.W., 
D.D.H., E.M.M.V.L., and T.S.). 
Infectious complications were divided into superficial (i.e., minor) and deep (i.e., 
major) using the criteria from the Centers for Disease Control and Prevention to define a 
surgical site infection (19). Superficial infections could be treated nonoperatively (e.g., 
using oral antibiotics). Infections that required surgical intervention, readmission, or 
intravenous antibiotics were classified as deep infections (15).  
The fractures were classified according to Essex-Lopresti (20) and Sanders et al 
(21). Böhler’s angle was measured from the trauma and follow-up radiographs. The 
patients were queried regarding their dominant side, smoking habits, and work and sports 
activities at the age of trauma and at follow-up. Furthermore, the cosmetic result observed 
by the patients and any shoe adjustments were queried.  
Patient-reported functional outcome was measured using validated questionnaires, 
which were sent by mail in September 2012. The Foot Function Index (primary outcome 
measure) was developed to measure the effect of the foot pathologic features on function 
in terms of pain, disability, and activity restriction (22). Twenty-three questions were 
scored from 1 (no pain, no difficulty, none of the time) to 10 (worst pain imaginable, so 
difficult or unable, all the time). The final maximum score could reach 100 points, with a 
higher score indicating more disability. 
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The American Orthopaedic Foot and Ankle Society hindfoot scale includes 9 
questions related to the subdomains of pain (1 question; 40 points), function (7 questions; 
50 points), and alignment (1 question; 10 points) (23,24). The maximum score is 100. 
The Short Form-36 (SF-36) questionnaire is a validated multipurpose health survey 
with 36 questions, representing 8 health domains that are combined into physical (PCS) 
and mental component summaries (25,26). Scores from 0 to 100 points are derived for 
each domain, with lower scores indicating poorer function. The 1998 U.S. population was 
used as the reference because weighing factors for the PCS and mental component 
summary for the Dutch population are not available. 
The EQ-5D is a validated questionnaire for health-related quality of life (27,28). 
The EQ-VAS is a standard vertical 20-cm visual analog scale for recording an individual’s 
rating of their current health-related quality of life. 
A 10-point visual analog scale, with 0 implying maximum dissatisfaction and 10, 
full satisfaction, was used to measure patient satisfaction with the overall outcome (18). 
The assessors of outcome (A.S.D.B., E.M.M.V.L.) were not involved in patient treatment. 
The data were analyzed by 2 of us (E.M.M.V.L. and T.S.) using the Statistical 
Package for the Social Sciences, version 20 (SPSS, Chicago, IL). Continuous data were 
found to deviate from a standard normal distribution (determined by inspecting frequency 
histograms and Q–Q plots) and are expressed as the median and first to third quartile (P25-
P75). Kruskal-Wallis analysis of variance with post hoc pairwise comparison using a 
Mann-Whitney U test was performed to assess the statistical significance of the continuous 
data among the treatment groups. Categorical data are presented as numbers and 
percentages and were analyzed using chi-square tests. A p value of < .05 was taken as the 
threshold of statistical significance. 
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RESULTS 
Demographic data 
During the 10-year study period, 178 patients were treated for a displaced intra-
articular calcaneal fracture. Nine patients were excluded from the present study because 
the Sanders classification could not be determined owing to missing radiologic images or 
insufficient image quality. Clinical data were collected for the remaining 169 patients. Of 
the 169 patients, 59 had been treated nonoperatively, 49 with ORIF, and 61 percutaneously 
(Table 1). The median age at trauma was 41 years (P25-P75 33 to 50), and 130 patients 
(77%) were male. The right calcaneus was fractured in 77 patients (46%), and 23 patients 
(14%) had a bilateral calcaneal fracture. The fractures had mainly resulted from a fall from 
a height (n = 104; 62%) or low energy trauma (n = 38; 22%). Of the 169 patients, 45 
(27%) had additional injuries. These baseline characteristics were not significantly 
different statistically among the 3 treatment groups.  
When classified according to Essex-Lopresti (20), most of the fractures were of a 
joint depression type (n = 97; 57%) or a tongue type (n = 58; 34%). Comminuted fractures 
(not classifiable as joint depression or tongue type) were found in only 8 patients, 7 of 
which were treated with ORIF (p = .007). In each of the 3 groups, approximately 80% of 
fractures were Sanders type II.  
Of the 169 patients, 108 were invited to complete the questionnaires because 61 
had met an exclusion criterion (Fig. 1). Of the 108 patients, 78 returned the questionnaire 
(response rate 72%). Of the 78 respondents, 18 (23.1%) had been treated nonoperatively, 
27 (34.6%) with ORIF, and 33 (42.3%) percutaneously (Table 2). The respondents had 
patient and fracture characteristics similar to those for the total study population of 169 
patients. The median body mass index was 25 kg/m2, 10 patients reported cardiovascular 
disease or diabetes, and 42% smoked at the time they had sustained the trauma. The 
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patients’ preferred (dominant) side was affected in 60% of the patients (Table 2). These 
characteristics were not significantly related to the treatment received. The same was true 
for the duration of plaster immobilization and non-weightbearing (Table 2).  
Table 1: Characteristics and outcome for entire study population (N=169) 
 
Overall 
(N=169) 
Non-operative 
(N=59) 
ORIF 
(N=49) 
Percutaneous 
(N=61) 
P-value* 
Age at trauma† (years) 41 (33-50) 40 (32-50) 41 (33-50) 44 (34-51) .573 / .542 
Male gender‡ 130 (77%) 46 (78%) 38 (78%) 46 (75%) .939 / .825 
Affected side‡      
Right side 77 (46%) 27 (46%) 24 (49%) 26 (43%) .551 / .649 
Left side 69 (41%) 21 (36%) 21 (43%) 27 (44%)  
Bilateral 23 (14%) 11 (19%) 4 (8%) 8 (13%)  
Trauma mechanism‡      
LET 38 (22%) 13 (22%) 13 (27%) 12 (20%) .130 / .453 
HET fall from height 104 (62%) 32 (54%) 32 (65%) 40 (66%)  
HET other 5 (3%) 1 (2%) 1 (2%) 3 (5%)  
Other 1 (1%) 0 (0%) 1 (2%) 0 (0%)  
Unknown 21 (12%) 13 (22%) 2 (4%) 6 (10%)  
Concomitant injuries‡ 45 (27%) 17 (29%) 12 (24%) 16 (26%) .238 / .528 
Essex-Lopresti classification‡      
Tongue Type 58 (34%) 18 (31%) 17 (35%) 23 (38%)          .007§/ .011§ 
Joint depression 97 (57%) 36 (61%) 25 (51%) 36 (59%)  
Comminuted 8 (5%) 1 (2%) 7 (14%) 0 (0%)  
Sanders classification‡      
Sanders II 132 (78%) 48 (81%) 38 (78%) 46 (75%) .291 / .919 
Sanders III 27 (16%) 5 (8%) 10 (20%) 12 (20%)  
Sanders IV 7 (4%) 4 (7%) 1 (2%) 2 (3%)  
Surgical delay† (days) 5 (2-7) N.A. 6 (3-11) 2 (1-6) N.A. /<.001§ 
Clinical follow-up† (months) 12 (5-19) 9 (1-16) 13 (9-19) 13 (6-25) .001§‖ / .907 
Follow-up > 30 d‡ 149 (88%) 44 (75%) 47 (96%) 58 (95%) <.001§ /1.000 
Adverse event (incl. infection) ‡ 56 (33%) 14 (24%) 14 (29%) 28 (46%) .026§ / .077 
Infection2 16 (9%) N.A. 8 (16%) 8 (13%) N.A. / .787 
Surgical site infection 7 (44%) N.A. 5 (63%) 2 (25%) N.A. / .315 
Deep infection 9 (56%) N.A. 3 (38%) 6 (75%)  
Late intervention  
   (excl. implant removal) ‡ 
32 (19%) 8 (14%) 6 (12%) 18 (30%) .030§ / .037§ 
Subtalar arthrodesis 19 (59%) 7 (88%) 0 (0%) 12 (67%) .002§ / .004§ 
Exostosis resection 5 (16%) 1 (13%) 1 (17%) 3 (17%)  
Wound debridement 5 (16%) 0 (0%) 2 (33.3) 3 (17%)  
Revision surgery 3 (9%) 0 (0%) 3 (50.0) 0 (0%)  
Implant removal‡ 59 (35%) N.A. 19 (39%) 40 (66%) N.A. / .007§ 
Time until implant removal† (weeks)1 28 (17-52) N.A. 55 (36-69) 22 (16-30) N.A. / <.001§ 
Abbreviations: HET, high energy trauma; LET, low energy trauma; NA, not applicable; ORIF, open 
reduction and internal fixation. 
Data presented as median (25th percentile to 75th percentile) or n (%). 
* First p value from comparison of the 3 treatment groups; second p value for comparison of 2 surgical groups. 
† Kruskal-Wallis analysis of variance. 
‡ Chi-square analysis. 
§ Difference found between nonoperative group and ORIF and percutaneous groups (both p = .001). 
‖ Statistically significant. 
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The period of clinical follow-up differed significantly among the 3 treatment 
groups for the overall population of 169 patients (Kruskal-Wallis p = .001; Table 1). The 
median clinical follow-up at the outpatient department was shorter in the nonoperative 
group (median 9 months, P25-P75 1 to 16) than in the ORIF group (median 13 months, P25-
P75 10 to 19; p = .001) or the percutaneous group (13 months, P25-P75 6 to 25; p = .001). In 
the nonoperative group, 75% of the patients were seen at regular intervals extending to 30 
days. In the ORIF and percutaneous groups, 96% and 95% of patients were seen at the 
outpatient department for longer than 30 days. Transfer to a hospital abroad and refusal 
were the main reasons for not returning to the outpatient department. Only the patients 
who had attended the outpatient department for their entire clinical follow-up period were 
invited for the present study to report on their long-term functional outcome (Table 3). 
This resulted in monitoring for longer than 30 days in 99% of the responders, with a 
median follow-up period of 14 months. A total of 108 patients were sent the 
questionnaires, of whom 78 responded (72% response rate).  
Fig. 1 Study flowchart. ORIF, open reduction and internal fixation. 
 
 
 
169 patients treated 
(1-1-2002 to 31-12-2011) 
61 excluded 
- 55 not attainable (address, abroad) 
- 4 died 
- 1 psychiatric disorder 
- 1 Cognitive problem due to brain tumor  
 
108 invited to participate 
 
78 returned 
questionnaire 
 
Non-operative 
18 patients 
Percutaneous 
33 patients 
ORIF 
27 patients 
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Table 2: Characteristics of patients who returned the questionnaire (N=78) 
 
Overall 
(N=78) 
Non-operative 
(N=18) 
ORIF 
(N=27) 
Percutaneous 
(N=33) 
P-value* 
Age at trauma (years) † 46 (36-55) 44 (34-59) 45 (34-56) 47 (40-54) .697 / .435 
Male gender‡ 59 (76%) 14 (78%) 20 (74%) 25 (76%) .960 / 1.000 
BMI (kg/m2) † 25 (22-27) 24 (22-27) 23 (22-27) 26 (23-28) .174 / .070 
Affected side2:      
Right side 33 (42%) 6 (33%) 15 (52%) 13 (39%) .511 / .292 
Left side 36 (46%) 9 (50%) 12 (44%) 15 (45%)  
Bilateral 9 (12%) 3 (17%) 1 (4%) 5 (15%)  
Dominant side affected‡ 47 (60%) 13 (72%) 15 (56%) 19 (58%) .491 / 1.000 
Trauma mechanism‡      
LET 20 (26%) 3 (17%) 10 (37%) 7 (21%) .479 / .311 
HET fall from height 47 (60%) 11 (61%) 15 (56%) 21 (64%)  
HET other 2 (3%) 1 (6%) 0 (0%) 1 (3%)  
Other 1 (1%) 0 (0%) 1 (4%) 0 (0%)  
Unknown 8 (10%) 3 (17%) 1 (4%) 4 (12%)  
Concomitant injury‡ 18 (23%) 7 (39%) 4 (15%) 7 (21%) .253 / .457 
Co-morbidity‡ 10 (13%) 4 (22%) 0 (0%) 6 (18%) .044§ / .028§ 
Cardiovascular disease 6 (8%) 3 (17%) 0 (0%) 3 (9%) .112 / .245 
Diabetes mellitus 4 (5%) 1 (6%) 0 (0%) 3 (9%) .282 / .245 
Smoking at age of trauma‡ 33 (42%) 9 (50%) 9 (33%) 15 (45%) .482 / .430 
Essex-lopresti classification‡      
Tongue Type 35 (45%) 8 (44%) 13 (48%) 14 (42%) .060 / .053 
Joint depression 39 (50%) 10 (56%) 10 (37%) 19 (58%)  
Comminuted 4 (5%) 0 (0%) 4 (15%) 0 (0%)  
Sanders classification‡      
Sanders II 63 (81%) 16 (89%) 21 (78%) 26 (79%) .236 / 1.000 
Sanders III 14 (18%) 1 (6%) 6 (22%) 7 (21%)  
Sanders IV 1 (1%) 1 (6%) 0 (0%) 0 (0%)  
Surgical delay (days) † 5 (2-7) N.A. 6 (3-8) 3 (1-7) N.A. / .011§ 
Clinical follow-up (months) † 14 (9-24) 13 (6-24) 16 (12-21) 14 (8-30) .406 / .899 
 Follow-up >30 days‡ 77 (99%) 17 (94%) 27 (100%) 33 (100%)  .185/ 1.000 
Plaster immobilization‡ 33 (42%) 10 (56%) 10 (37%) 13 (39%) .230 / 1.000 
Plaster immobilization (weeks) ‡ 6 (3-10) 9 (4-13) 4 (1-8) 6 (6-9) .184 / .117 
Non-weight bearing (weeks) † 12 (8-13) 12 (8-14) 12 (12-13) 12 (7-13) .534 / .278 
 
Abbreviations: HET, high energy trauma; LET, low energy trauma; NA, not applicable; ORIF, open 
reduction and internal fixation. 
Data presented as median (25th percentile to 75th percentile) or n (%). 
* First p value from comparison of the 3 treatment groups; second p value for comparison of 2 surgical groups. 
† Kruskal-Wallis analysis of variance. 
‡ Chi-square analysis. 
§ Statistically significant. 
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Adverse Events, Late Interventions, and Implant Removal  
Of all 169 patients, 56 (33%) experienced an adverse event, including 16 patients 
who developed an infection. The prevalence of adverse events was lowest in the 
nonoperative group (n = 14; 24%) and greatest in the percutaneous group (n = 28; 46%;  
p =.026; Table 1). 
The difference in the prevalence of infections between the 2 operative methods was 
not significant 16% (5 superficial and 3 deep) in the ORIF group and 13% (2 superficial 
and 6 deep) in the percutaneous group (p = .315 comparing superficial and deep infection 
in the operative groups; Table 1).  
Late intervention (excluding implant removal) was performed in 32 patients (19%). 
This percentage was significantly greater in the percutaneous group (n = 18; 30%) than in 
the ORIF group (n = 6; 12%) or nonoperative group (n = 8; 14%; p = .030; Table 1).  
The main late intervention (excluding implant removal) was subtalar arthrodesis in 
19 patients, followed by exostosis resection in 5, wound debridement in 5, and revision of 
the osteosynthesis surgery in 3. Secondary arthrodesis was performed most frequently in 
the nonoperative group (7 of 8 patients undergoing late intervention; 88%; p = .002), 
followed by the percutaneous group (12 of 18, 67%; p = .004), and was not needed in the 
ORIF group. 
Overall, arthrodesis was performed in 12% of patients in the nonoperative group and 20% 
of patients in the percutaneous group.  
Implants were removed more frequently in the percutaneous group (n = 40; 66%) 
than in the ORIF group (n = 19; 39%; p = .007; Table 1). In addition to the lower 
prevalence of removal, the implants remained in situ for a significantly longer period in 
the ORIF group (median 55 weeks, P25-P75 36 to 69) than in the percutaneous group 
(median 22 weeks, P25-P75 16 to 30; p < .001; Table 1).  
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Patient-reported Outcome Measures 
Questionnaires were completed by 78 patients (18 treated nonoperatively, 27 with 
ORIF, and 33 percutaneously). The Functional Foot Index score differed significantly 
among the treatment groups, with the greatest disability reported by the nonoperative 
group (median overall score 40 points; Table 4 and Fig. 2A). This was significantly greater 
than in the ORIF group (16 points; p = .010) or the percutaneous group (21 points; p = 
.034). This was mainly attributable to differences in the subdomain activity limitation. The 
median American Orthopaedic Foot and Ankle Society hindfoot score ranged from 61 
points in the nonoperative group to 81 in the percutaneous group. No statistically 
significant relation with treatment was found, neither in the overall score nor in the 
individual subdomains. However, the data suggested a trend in favor of operative 
treatment. 
The median visual analog scale score for patient satisfaction ranged from 6.3 in the 
nonoperative group to 8.5 in the percutaneous group (p > .05). 
The SF-36 mental component summary score was similar in all treatment groups, 
with all median values within the normal range of 50 ± 10 points (Table 4 and Fig. 3B). 
However, the median PCS score was below the normality boundaries in the nonoperative 
group (38 points). The median PCS score was 50 in the percutaneous group and 52 in the 
ORIF group. The difference between the operative and nonoperative groups did not reach 
statistical significance (p = .050; Table 4 and Fig. 3A). 
The EQ-5D utility score (median 0.78, P25-P75 0.77 to 0.93) and EQ-visual analog 
scale score (median 80, P25-P75 70 to 89) were unrelated to the treatment used.  
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Table 3: Clinical and cosmetic outcome in patients who returned the questionnaire (N=78) 
 
 
Overall 
(N=78) 
Non-operative 
(N=18) 
ORIF 
(N=27) 
Percutaneous 
(N=33) 
P-value* 
Follow-up (months) † 76 (54-88) 78 (51-88) 56 (28-76) 88 (68-107) <.001‡/<.001‡ 
Working pre-fracture‡ 78 (100%) 18 (100%) 27 (100%) 33 (100%) 1.000 / 1.000 
Heaviness of work‡      
Heavy 19 (24%) 6 (33%) 7 (26%) 6 (18%) .515 / .777 
Mild 33 (42%) 9 (50%) 10 (37%) 14 (42%)  
Light 25 (32%) 3 (17%) 10 (37%) 12 (36%)  
Work resumption at FU‡ 63 (81%) 13 (72%) 26 (96%) 24 (73%) .052 / .031‡ 
Returned to same position 44 (56%) 7 (39%) 21 (78%) 16 (48%) .016‡ / .043‡ 
Returned to changed position 19 (24%) 7 (39%) 5 (19%) 7 (21%)  
Unable to work due to complaints 10 (13%) 4 (22%) 1 (4%) 5 (15%)  
Pension or unknown 5 (6%) 0 (0%) 0 (0.0) 5 (15%)  
Sports activities pre-fracture‡ 37 (47%) 9 (50%) 14 (52%) 14 (42%) .744 / .604 
Sports activities resumed at FU‡ 28 (36%) 5 (28%) 10 (37%) 13 (39%) .702 / 1.000 
Walking barefoot‡      
No problems 46 (59%) 8 (44%) 19 (70%) 19 (57%) .360 / .545 
With problems 30 (38%) 10 (56%) 7 (26%) 13 (39%)  
Unable to do 2 (3%) 0 (0%) 1 (4%) 1 (3%)  
Able to run‡ 43 (55%) 9 (50%) 17 (63%) 17 (52%) .596 / .438 
Stiffness‡ 61 (78%) 18 (100%) 23 (85%) 20 (61%) .003‡ / .046‡ 
Continuous 31 (51%) 10 (56%) 12 (52%) 9 (45%) .799 / .763 
Only in the morning 30 (49%) 8 (44%) 11 (48%) 11 (55%)  
Change in shoe size‡ 22 (28%) 5 (28%) 8 (30%) 9 (27%) .979 / 1.000 
Size change † 1.0 (1.0-1.0) 1.0 (-0.1-1.0) 1.0 (0.6-1.0) 1.0 (1.0-2.0) .184 / .131 
Changes in type of shoe‡      
Unchanged / mild concession 53 (68%) 8 (44%) 21 (78%) 24 (73%) .186 / .885 
Slight orthopedic changes (insoles) 12 (15%) 5 (28%) 3 (11%) 4 (12%)  
Orthopedic shoes / shoes impossible 13 (17%) 5 (28%) 3 (11%) 5 (15%)  
Change in foot shape‡      
Unchanged 19 (24%) 3 (17%) 6 (22%) 10 (30%) .440 / .295 
Mild changes 42 (54%) 9 (50%) 18 (67%) 15 (45%)  
Moderate changes 13 (17%) 4 (22%) 3 (11%) 6 (18%)  
Major changes 4 (5%) 2 (11%) 0 (0%) 2 (6%)  
Adverse event (incl. infection) ‡ 27 (5%) 4 (22%) 9 (33%) 14 (42%) .345 / .595 
Infection‡ 11 (14%) N.A. 5 (19%) 6 (18%) N.A. / 1.000 
Surgical site infection 6 (55%) N.A. 4 (80%) 2 (33%) N.A. / .242 
Deep infection 5 (45%) N.A. 1 (20%) 4 (67%)  
Late intervention 
    (excl. implant removal) ‡ 
14 (18%) 1 (6%) 4 (15%) 9 (27%) .135 / .348 
Subtalar arthrodesis 7 (50%) 1 (100%) 0 (0%) 12 (67%) .187 / .057 
Exostosis resection 2 (14%) 0 (0%) 1 (25%) 1 (11%)  
Wound debridement 3 (21%) 0 (0%) 1 (25%) 2 (22%)  
Revision surgery 2 (14%) 0 (0%) 2 (50%) 0 (0%)  
Implant removal‡ 36 (46%) N.A. 10 (37.0) 26 (78.8) N.A. / .001‡ 
Time until implant removal† (weeks) 25 (14-42) N.A. 55 (30-71) 23 (12-32) N.A. / .014‡ 
 
Abbreviations: FU, follow-up; NA, not applicable; ORIF, open reduction and internal fixation. 
Data presented as median (25th percentile to 75th percentile) or n (%). 
* First p value from comparison of the 3 treatment groups; second p value for comparison of 2 surgical groups. 
† Kruskal-Wallis analysis of variance. 
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‡ Chi-square analysis. 
§ Statistically significant. 
Work Resumption, Sports Resumption, and Cosmesis  
All 78 patients had worked before their trauma, with no significant difference in 
the number of patients performing heavy labor among the treatment groups (Table 3). 
Patients in the ORIF group had resumed work in 96% of cases, significantly more than that 
in the percutaneous group (75%; p = .045). In the nonoperative group, 72% had returned to 
work at the time of completing the questionnaires. Because of the lower number of 
patients in the nonoperative group, this was not significantly different statistically from the 
rate in the operative groups. In addition to resuming work more often, a significantly 
greater proportion of the ORIF group had returned to the same position as before their 
injury. 
Of the 78 patients, 37 (47%) had participated in sports activities before their injury. 
At the last follow-up point, 28 (76%) had resumed their sports activities, irrespective of the 
treatment type.  
Also, 46 patients (59%) were able to walk barefoot without problems, and 43 were 
able to run. Again, no relation with treatment was found. All patients in the nonoperative 
group reported stiffness of the ankle compared with 85% in the ORIF group and 61% in 
the percutaneous group (p = .003; Table 3). A total of 22 patients reported changes in shoe 
size, 59 reported a change in foot shape, and 25 reported the use of adjusted shoes at 
follow-up compared with before fracture. These findings were not associated with the 
treatment modality (Table 3). 
 
DISCUSSION 
In the present retrospective study, patients with a displaced intra-articular calcaneal 
fracture generally showed better functional outcomes after operative treatment (i.e., ORIF 
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and percutaneous treatment) than after nonoperative treatment. Although a greater 
percentage of patients in the operative treatment groups had adverse events (including 
infections) and late interventions, the patient-reported outcome scores were better in the 
operative groups. 
Table 4: Functional outcome and quality of life in patients who returned the 
questionnaire (N=78) 
 Overall 
(N=78) 
Non-operative 
(N=18) 
ORIF 
(N=27) 
Percutaneous 
(N=33) 
P-value 
FFI: 
  Overall score 
 
22 (7-37) 
 
40 (10-69) 
 
16 (7-29) 
 
21 (4-37) 
 
.031* 
Pain 26 (9-48) 47 (11-68) 20 (9-41) 21 (2-45) .063 
Disability 19 (8-50) 52 (11-70) 16 (1-34) 17 (2-47) .077 
Activity limitation 5 (0-17) 16 (5-51) 4 (0-6) 2 (0-21) .017† 
AOFAS:  
  Overall score 
 
77 (59-89) 
 
61 (43-78) 
 
76 (64-85) 
 
81 (66-95) 
 
.060 
Pain 30 (20-30) 20 (20-30) 30 (20-30) 30-(20-40) .132 
  Function 40 (32-47) 31 (20-41) 41 (34-47) 42 (34-48) .069 
  Alignment 10 (5-10) 10 (4-10) 10 (5-10) 10 (8-10) .208 
SF-36:   
   PCS 
 
48 (36-54) 
 
38 (27-53) 
 
52 (42-57) 
 
50 (38-54) 
 
.050 
MCS 57 (47-61) 54 (45-60) 58 (56-61) 57 (45-62) .490 
EQ-5D: 
  EQUS 
 
0.78 (0.77-0.93) 
 
0.78 (0.52-0.81) 
 
0.81 (0.78-0.93) 
 
0.78 (0.78-0.93) 
 
.095 
EQVAS 80 (70-89) 75 (63-83) 80 (75-90) 80 (70-90) .102 
Patient satisfaction 
(VAS) 
 
8.0 (6.0-9.5) 
 
6.3 (3.8-9.5) 
 
8.0 (6.0-9.5) 
 
8.5 (7.0-10.0) 
 
.081 
 
Abbreviations: AOFAS, American Orthopaedic Foot and Ankle Society hindfoot score; CI, confidence interval; EQ-5D, 
EuroQol-5D; EQUS, EuroQol utility score; EQVAS, EuroQoL visual 
analog scale; FFI, Foot Function Index; MCS, mental component summary; PCS, physical component summary; SF-36, 
Short Form-36; VAS, visual analog scale. 
Data presented as median (25th to 75th percentile). 
Kruskal-Wallis analysis of variance used to assess statistical significance between the treatment groups, followed by post 
hoc pairwise comparisons using the Mann-Whitney U test if 
significantly different. 
* Statistically significant difference found between nonoperative and ORIF groups (p = .010) and nonoperative and 
percutaneous groups (p = .034). 
† Statistically significant difference found between nonoperative and ORIF groups (p = .004) and nonoperative and 
percutaneous groups (p = .025). 
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The nonoperatively treated patients reported more difficulties, such as shoe adjustments 
and hindfoot stiffness, and returned to work later. Of the 2 surgical procedures, the results 
were in favor of the ORIF treatment strategy. In the percutaneous group, more 
complications were seen, implants had to be removed more often, and patients required 
late intervention more frequently.  
The published data have indicated that less invasive procedures might allow 
accelerated weightbearing, less joint stiffness, and greater patient’ satisfaction compared 
with ORIF (29,30). However, in the present study, ORIF provided better results. Almost 
one fifth of the percutaneously treated patients required secondary arthrodesis compared 
with none in the ORIF group. The 20% secondary arthrodesis rate after percutaneous 
treatment found in the present study was comparable to the previously reported 15% (18).  
ORIF treatment has been known for infectious complications (1). In our study, 
16% of patients in the ORIF group (8 of 49) experienced an infectious complication, 
which was not much different from the 13% in the percutaneous group. This infection rate 
of 13% was comparable to that in previous reports (31). Thus, the functional results in our 
study were not negatively affected by a learning curve of the surgeons in our medical 
center or a high infection rate. Although the implant removal rate of 39% for ORIF was 
comparable to that of other reports (39% to 49%) (32,33), the 57% rate in the percutaneous 
group was much greater than the 12% reported previously (34). Considering the 
complaints of the patients in our study, it is plausible that the large screw head of the 
implants used for the percutaneous treatment was the cause of the high rate of implant 
removal (18,31). Especially for percutaneous treatment, less prominent implants (i.e., 
headless screws) should be considered (35,36).  
The response percentage for the different treatments groups was 31% (18 of 59 
patients) in the nonoperative group, 55% (27 of 49 patients) in the ORIF group, and 54% 
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(33 of 61 patients) in the percutaneous group, indicating that fewer conservatively treated 
patients completed the questionnaires. The response percentage of both operative 
treatment groups was nearly identical.  
Although nonoperative treatment of calcaneal fractures did not lead to the best 
results, it could still be a viable treatment modality given the noncompliance of some 
patients concerning mobilization advice during follow-up. Early studies (37,38) showed 
that early exercise will be the best nonoperative modality. The nonoperatively treated 
patients reported inferior functional outcomes and more disability in the questionnaires 
than did the operatively treated patients. This might explain why the vast majority of late 
interventions in the nonoperative group were secondary arthrodesis. 
Several comparative studies have described the results of ORIF and nonoperative 
management but did not use a standardized functional outcome scoring system (39–42). 
Studies comparing ORIF and nonoperative management that did use a disease-specific 
outcome score have shown conflicting results. Three studies reported a significantly 
greater outcome for operatively treated fractures (43–46). In another study, only a trend 
toward a better outcome in the operative group was seen (47). Two studies failed to find a 
significant difference (48,49).  
Just as with any retrospective study, we acknowledge the presence of limitations. 
The follow-up duration was different among the treatment groups because of a changes in 
the local protocol during the study period. The preferred surgical treatment changed from 
percutaneous to ORIF from 2005 onward. To some extent, the difference in functional 
outcome scores could have resulted from the differences in the interval between the trauma 
and questionnaire completion. With a median follow-up of 56 and 88 months, the ORIF 
and percutaneous groups had, overall, significantly better outcomes than did the 
nonoperatively treated patients, who had completed the questionnaires after 78 months. 
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Clinical data could be retrieved for 9 months in the nonoperative group compared with 13 
months in both operative groups. A shorter clinical follow-up period for the conservative 
group might have resulted in an underestimation of the true rate of complications and late 
interventions. This underestimation for the infectious complication rate in the present 
study was probably minimal, because more than 95% of the patients in the operative 
groups were followed up for at least 30 days, which we believed would be a relevant 
period for the identification of delayed or problematic wound healing.  
. 
 
 
 
Another limitation was that of the 169 patients, only 108 (64%) met the eligibility criteria 
for an invitation to complete the questionnaires. The clinical data from the sample of 108 
Fig. 2. (A) Foot Function Index total score. (B) 
Foot Function Index subdomain scores. Nonop, 
nonoperative; ORIF, open reduction and internal 
fixation; Perc, percutaneous. 
 
Fig. 3. (A) Short Form-36 (SF-36) and physical 
component summary (PCS) scores. (B) SF- 
36 physical component summary score for the 
subdomains. BP, bodily pain; GH, general 
health; PF, physical functioning; RF, role 
physical. 
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patients were similar to the data from the total population of 169 patients, supporting the 
idea that the invitees were representative of the total population. The response rate for the 
questionnaires was 72%, consistent with that previously reported (50). This could have 
introduced some selection bias. Because the response percentage was comparable in each 
treatment group, the bias could not explain the differences found.  
Minimally invasive, percutaneous treatment has often been chosen in patients with 
comorbidities, which might explain the complications in the percutaneous group. The 
differences in the complication rates between the percutaneous and ORIF groups should 
thus be interpreted with care. No difference in any of the observed patient characteristics 
(i.e., gender, age at trauma, smoking, diabetes mellitus and other comorbidities) or injury 
characteristics (i.e., affected side, trauma mechanism, injury classification, and 
concomitant injuries) among the treatment groups was noted in our study. Therefore, any 
consequent bias can be assumed to be, at most, marginal.  
Concomitant injuries are not rare with calcaneal fractures. In the published data, 
there are indications that polytrauma patients with calcaneal fractures have had a worse 
clinical outcome than patients with isolated calcaneal fractures. The present study lacked 
statistical power to evaluate the relationship between polytrauma and functional outcome 
stratified by treatment modality. 
In conclusion, our results have indicated that operatively treated patients report 
improved outcomes and better Foot Function Index and American Orthopaedic Foot and 
Ankle Society hindfoot scale score compared with the nonoperatively treated patients. 
These results support previous data (51–53). Patients treated with ORIF had the best 
outcome measures. In the present study, both functional and patient-related outcomes from 
the 3 different treatment strategies for displaced intra-articular calcaneal fractures were 
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investigated. Overall, ORIF resulted in superior functional outcomes and greater patient 
satisfaction, with an acceptable complication rate and no secondary arthrodesis required. 
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